Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029
Clinical trial NCT05428449 · COMPLETED
Trial details
- NCT number
- NCT05428449
- Sponsor
- Suzhou Kintor Pharmaceutical Inc,
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-10
- Primary completion
- 2022-10-27
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.